StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

CannaPharmaRx's net income for the twelve months ending Sep 30, 2026 was -$9.20M. For fiscal 2025 it was -$11.13M. The highest annual figure on record is $3.69M in fiscal 2023.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.13M–
FY2024Dec 31, 2024-$9.91M-368.6%
FY2023Dec 31, 2023$3.69M–
FY2022Dec 31, 2022-$8.53M–
FY2021Dec 31, 2021-$8.83M–
FY2020Dec 31, 2020-$19.89M–
FY2019Dec 31, 2019-$20.45M–
FY2018Dec 31, 2018-$3.09M–
FY2017Dec 31, 2017-$6.63K–
FY2016Dec 31, 2016-$1.00M–
FY2015Dec 31, 2015-$11.74M–
FY2014Dec 31, 2014-$3.98M–
FY2013Dec 31, 2013-$94.41K–
FY2012Dec 31, 2012-$98.07K–
FY2011Dec 31, 2011-$99.66K–
FY2010Dec 31, 2010-$99.66K-191.5%
FY2009Dec 31, 2009$108.86K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$645.42K–
Q2 FY2026Jun 30, 2026-$1.91M–
Q1 FY2026Mar 31, 2026-$382.02K–
Q4 FY2025Dec 31, 2025-$7.55M–
Q3 FY2025Sep 30, 2025-$1.48M-884.3%
Q2 FY2025Jun 30, 2025-$1.41M-126.4%
Q1 FY2025Mar 31, 2025-$690.59K–
Q4 FY2024Dec 31, 2024-$3.74M-149.6%
Q3 FY2024Sep 30, 2024$188.42K–
Q2 FY2024Jun 30, 2024$5.36M–
Q1 FY2024Mar 31, 2024-$11.72M–
Q4 FY2023Dec 31, 2023$7.54M–
Q3 FY2023Sep 30, 2023-$564.37K–
Q2 FY2023Jun 30, 2023-$1.88M–
Q1 FY2023Mar 31, 2023-$1.41M–
Q4 FY2022Dec 31, 2022-$3.64M–
Q3 FY2022Sep 30, 2022-$1.31M–
Q2 FY2022Jun 30, 2022-$1.51M–
Q1 FY2022Mar 31, 2022-$2.07M-273.0%
Q4 FY2021Dec 31, 2021-$7.34M–
Q3 FY2021Sep 30, 2021-$1.03M–
Q2 FY2021Jun 30, 2021-$1.67M–
Q1 FY2021Mar 31, 2021$1.20M–
Q4 FY2020Dec 31, 2020-$11.55M–
Q3 FY2020Sep 30, 2020-$2.65M–
Q2 FY2020Jun 30, 2020-$1.47M–
Q1 FY2020Mar 31, 2020-$4.21M–
Q4 FY2019Dec 31, 2019-$9.31M–
Q3 FY2019Sep 30, 2019-$9.32M–
Q2 FY2019Jun 30, 2019-$748.08K–
Q1 FY2019Mar 31, 2019-$1.07M–
Q4 FY2018Dec 31, 2018-$1.93M–
Q3 FY2018Sep 30, 2018-$1.09M–
Q2 FY2018Jun 30, 2018-$70.50K–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017-$4.97K–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017-$70.50K–
Q1 FY2017Mar 31, 2017-$1.67K–
Q4 FY2016Dec 31, 2016-$36.22K–

More CannaPharmaRx figures

See a number that looks wrong?